How the American Heart Association Focuses on the Entire Cardiovascular System

 

This week on I Don’t Care with Kevin Stevenson, he sits down with Michelle Stoddard and Dr. Abe DeAnda to discuss how the American Heart Association goes past just cardiac care and how the organization aims to work closely within their local communities.

While the heart may be at the well, heart of what the American Heart Association does, this prestigious pillar of the medical pillar works tirelessly to protect so much more than our hearts. According to Dr. Abe DeAnda, Professor and Chief, Cardiovascular and Thoracic Surgery at the American Heart Association at UTMB in Galveston, the research they do at the American Heart Association benefits the entire body. “It’s not just the heart, it’s cardiovascular. So it’s your vessels, including your cerebral vascular vessels. So every bit of research that occurs, is going to be anything that has a blood vessel, alright so not just your heart,” Dr. DeAnda said.

He went on to explain that the heart affects the aorta, peripheral vascular system, legs, kidneys, essentially everything in the body. “When you have claudication, when it hurts to walk, or you have poor perfusion. It’s going to be your kidneys, when you’re not getting enough blood to your kidneys, it’s gonna be your brain when you have a stroke or you have some type of other cerebrovascular disease,” Dr. DeAnda explained.

Another image associated with the name of the association is that they do work that is felt only on a domestic level, but their work truly does have a global impact. “So if you can imagine an organization that’s funding that, it’s a big organization, right. It has to be, it’s your whole body and it’s dealing with the diseases that kill a lot of people in this country and worldwide. The other, I don’t want to really call it a misnomer, but the American part, this is worldwide. This is international,” Dr. DeAnda stated.

Catch up on previous episodes of I Don’t Care with Kevin Stevenson!

Follow us on social media for the latest updates in B2B!

Image

Latest

cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More
organoids
Growing the Future of Cancer Research: Inside the Promise of Organoids
April 19, 2025

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…

Read More